AKBA Operating Cash Flow
Akebia Therapeutics Inc · Operating Cash Flow
AKBA Operating Cash Flow
Latest reported$41.55Mperiod ending
AKBA TTM Operating Cash Flow (-$11.33M → $41.55M)
TTM operating cash flow
High-resolution chart · PNG
AKBA operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 41,552,000 | |
| 60,372,000 | |
| 67,992,000 | |
| 32,397,000 | |
| -2,403,000 | |
| -34,814,000 | |
| -40,659,000 | |
| -38,501,000 | |
| -38,973,000 | |
| -25,278,000 | |
| -23,384,000 | |
| -75,755,000 | |
| -34,783,000 | |
| -69,072,000 | |
| -73,154,000 | |
| -81,283,000 | |
| -171,358,000 | |
| -203,839,000 | |
| -252,965,000 | |
| -220,939,000 | |
| -191,906,000 | |
| -91,545,000 | |
| -110,388,000 | |
| -171,741,000 | |
| -133,515,000 | |
| -209,101,000 | |
| -257,441,000 | |
| -239,005,000 | |
| -262,455,000 | |
| -215,093,000 | |
| -97,494,000 | |
| -40,173,000 | |
| -82,329,000 | |
| -66,961,000 | |
| -56,159,000 | |
| 55,889,000 | |
| 82,263,000 | |
| 30,944,000 | |
| 57,906,000 | |
| -60,676,000 | |
| -41,464,000 | |
| -26,626,000 | |
| -52,407,000 | |
| -38,698,000 | |
| -35,269,934 | |
| -29,822,330 | |
| -27,483,000 | |
| -23,187,671 | |
| -20,522,285 | |
| -15,809,762 | |
| -11,331,671 | |
| -8,396,441 |